Fabry's disease was treated with 1-pyrethroid and alpha-Gal A instead of enzyme.

• 收藏
• 分享

专利权人:

AMICUS THERAPEUTICS INC.

发明人:

GREENE DOUGLAS STUART,VALENZANO KENNETH JOSEPH

申请号：

CL2013002601

公开号：

CL2013002601A1

申请日:

2013.09.10

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

The presently disclosed subject matter provides a dosing regimen and administration schedule for the use of 1-deoxygalactonojirimycin and enzyme replacement therapy for the treatment of Fabry disease. The presently disclosed subject matter further provides a dosing regimen and administration schedule for the use of migalastat hydrochloride and agalsidase for the treatment of Fabry disease.USO DE 1-DESOXIGALACTONOJIRIMICINA Y UNA TERAPIA DE REEMPLAZO DE ENZIMAS CON ALFA-Gal A PARA TRATAR LA ENFERMEDAD DE FABRY.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/